|
ANKRA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20790052907205E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79990466975255E-11 |
| Normal-vs-Stage2 |
2.163300E-04 |
| Normal-vs-Stage3 |
4.018500E-04 |
| Normal-vs-Stage4 |
1.663500E-03 |
| Stage1-vs-Stage2 |
8.803600E-01 |
| Stage1-vs-Stage3 |
1.914120E-02 |
| Stage1-vs-Stage4 |
7.782000E-03 |
| Stage2-vs-Stage3 |
1.268200E-01 |
| Stage2-vs-Stage4 |
8.727700E-02 |
| Stage3-vs-Stage4 |
7.751400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17179999037376E-09 |
| Normal-vs-AfricanAmerican |
1.436660E-04 |
| Normal-vs-Asian |
5.322200E-03 |
| Caucasian-vs-AfricanAmerican |
3.460400E-01 |
| Caucasian-vs-Asian |
7.490000E-01 |
| AfricanAmerican-vs-Asian |
9.586400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.52899964595599E-10 |
| Normal-vs-Female |
1.42520000023794E-07 |
| Male-vs-Female |
6.007000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.604800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.78380005106038E-09 |
| Normal-vs-Age(61-80Yrs) |
2.93659996319917E-09 |
| Normal-vs-Age(81-100Yrs) |
5.028300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.035800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.298000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.822800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.090000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.513200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.295600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.322600E-03 |
| Normal-vs-Grade 2 |
1.81044068625624E-12 |
| Normal-vs-Grade 3 |
3.4330999999499E-06 |
| Normal-vs-Grade 4 |
2.876000E-01 |
| Grade 1-vs-Grade 2 |
6.310800E-01 |
| Grade 1-vs-Grade 3 |
5.208100E-02 |
| Grade 1-vs-Grade 4 |
1.201450E-03 |
| Grade 2-vs-Grade 3 |
3.981900E-04 |
| Grade 2-vs-Grade 4 |
4.73319999860777E-08 |
| Grade 3-vs-Grade 4 |
8.755700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.0300428005271E-12 |
| Normal-vs-ccB subtype |
4.445800E-04 |
| ccA subtype-vs-ccB subtype |
6.28630000000241E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30559999478308E-08 |
| Normal-vs-N1 |
8.668800E-01 |
| N0-vs-N1 |
5.201500E-02 |
|
|
